Skip to main content

Table 1 Clinical characteristics of women with GDM and non-GDM

From: Association between second- and third-trimester maternal lipid profiles and adverse perinatal outcomes among women with GDM and non-GDM: a retrospective cohort study

Characteristics

Mean ± SD or N (%)

P

GDM group (n = 1632)

non-GDM group (n = 9067)

 

Maternal Age (years)

33.02 ± 4.36

30.80 ± 4.53

 < 0.001

 20–29

425(26.04)

3835(42.30)

 < 0.001

 30–34

650(39.83)

3409(37.60)

 

  ≥ 35

557(34.13)

1823(20.10)

 

Pre-pregnancy BMI (kg/m2)

21.64 ± 2.94

20.66 ± 2.64

 < 0.001

 Underweight (< 18.5)

228(13.97)

1804(19.90)

 < 0.001

 Normal weight (18.5–24.9)

1215(74.45)

6683(73.71)

 

 Overweight and obese (≥ 25.0)

189(11.58)

580(6.40)

 

Gestational weight gain

 Appropriate

696(42.65)

3752(41.38)

 < 0.001

 Inadequate

612(37.50)

3991(44.02)

 

 Excessive

324(19.85)

1324(14.60)

 

Maternal education [n (%)]

  ≤ Junior school

165(10.11)

917(10.11)

0.896

  High school

199(12.19)

1162(12.82)

 

  ≥ University

1268(77.69)

6988(77.07)

 

 Caesarean history [n (%)]

402(24.63)

2531(27.91)

 < 0.001

Parity

 Nulliparous

861(52.76)

5495(60.60)

 < 0.001

 Multiparous

771(47.24)

3572(39.40)

 

 IVF [n (%)]

176(10.78)

621(6.85)

 < 0.001

Mode of delivery [n (%)]

 Vaginal

890(54.53)

5423(59.81)

 < 0.001

 Cesarean

742(45.47)

3644(40.19)

 

 Gestational age (weeks, mean ± SD)

38.35 ± 1.75

37.58 ± 2.67

 < 0.001

 FPG on OGTT (mmol/L)

5.59 ± 0.83

4.12 ± 0.47

 < 0.001

 2-h blood glucose on OGTT (mmol/L)

8.75 ± 1.69

7.21 ± 1.92

 < 0.001

  1. GDM Gestational Diabetes Mellitus, IVF In-vitro fertilization, FPG Fasting plasma glucose, OGTT Oral glucose tolerance test
  2. SD Standard deviation, pp BMI Pre-pregnancy body mass index, IVF In-vitro fertilization, FBG Fasting Plasma Glucose, OGTT Oral glucose tolerance test